The National Action Plan for Prevention and Control of Snakebite Envenoming in India (NAPSE), launched in March 2024, is a crucial and timely initiative aimed at addressing one of the country’s most persistent public health challenges. Snakebites in India are responsible for nearly 50% of global snakebite deaths, with an estimated 50,000 fatalities annually out of 3–4 million snakebite cases.[1] The goal of NAPSE is to halve snakebite-related deaths and disabilities by 2030 through a comprehensive and multifaceted approach. This editorial delves into the key features, strategies, and implications of NAPSE, highlighting its potential to transform snakebite management in India.
BT - Journal of family medicine and primary care C1 - https://www.ncbi.nlm.nih.gov/pubmed/39723000 DA - 11/2024 DO - 10.4103/jfmpc.jfmpc_902_24 IS - 11 J2 - J Family Med Prim Care LA - ENG M3 - Letter to the editor N2 -The National Action Plan for Prevention and Control of Snakebite Envenoming in India (NAPSE), launched in March 2024, is a crucial and timely initiative aimed at addressing one of the country’s most persistent public health challenges. Snakebites in India are responsible for nearly 50% of global snakebite deaths, with an estimated 50,000 fatalities annually out of 3–4 million snakebite cases.[1] The goal of NAPSE is to halve snakebite-related deaths and disabilities by 2030 through a comprehensive and multifaceted approach. This editorial delves into the key features, strategies, and implications of NAPSE, highlighting its potential to transform snakebite management in India.
PY - 2024 SP - 5438 EP - 5439 T2 - Journal of family medicine and primary care TI - The national action plan for prevention and control of snakebite envenoming in India (NAPSE): Its role, opportunities and challenges. UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC11668436/pdf/JFMPC-13-5438.pdf VL - 13 SN - 2249-4863 ER -